Home › Zyoxel Announces The Performance Of Tests By Sanofi On The Power Of 3D Liver Culture Models For More Predictive And Insightful DMPK Studies
 

Keywords :   


Zyoxel Announces The Performance Of Tests By Sanofi On The Power Of 3D Liver Culture Models For More Predictive And Insightful DMPK Studies

2013-12-04 06:22:33| drugdiscoveryonline News Articles

Zyoxel, the world’s leading expert for advanced in vitro 3D liver models for drug discovery and drug testing, has announced preliminary results from a testing by Sanofi on Zyoxel’s LiverChip platform for drug metabolism and pharmacokinetic (DMPK) studies

Tags: power performance culture studies

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Flint Group retains EcoVadis Silver Medal for 2024
15.05Mark Andy hosts student workshop in Poland
15.05Kenvue Launches Aveeno Baby Healthy Start Wash and Balm
15.05Royal Mail owner poised to accept 3.5bn takeover bid
15.05Gold Bond Named Official Body Skin Sponsor of Sports Illustrated Swimsuit\'s 60th Anniversary Issue
15.05Dunn-Edwards Reveals New Multifamily Color Collection
15.05Kimberly-Clark Names Chief Growth Officer
15.05TV Personality Lo Bosworth and BIC Soleil Escape Razors Launch Limited-Edition Five Senses Shave Kit
More »